Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular Clodronate for Painful Knee Osteoarthritis
NCT06263517Phase 3Recruiting
- Sponsor
- Società Prodotti Antibiotici
- Start
- Oct 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clodronate in osteoarthritis (OA) (4 arms), sponsored by Società Prodotti Antibiotici. Primary endpoint: Visual Analogue Scale Reduction at Week 7. Started Oct 2023; status: recruiting.
02
Drugs
clodronate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06263517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06263517.